Abstract:Objective To investigate the changes of serum adiponectin and visfatin/pre-B cell colony-enhan cing factor(PBEF)levels in patients with metabolic syndrome(MS),so as to understand their association with MS.Methods According to the diagnostic criteria for MS recommended by the Chinese Medical Association in 2004,42 patients with MS were selected for this study with 30 healthy subjects as the control group.After mea- surement of the height,body weight and waist circumference,fasting blood samples were collected from all partici- pants to determine the fasting plasma glucose(FPG),serum insulin,adiponectin and visfatin levels.Radioimmuno- assay(RIA)was employed for serum adiponectin level measurement;enzyme-linked immunoassay(EIA)was used for visfatin detection;and homeostasis model assessment of insulin resistance(HOMA-IR)was calculated based on FPG and insulin measurements.Results①There were 22 males and 20 females in the MS group,with a mean age of(53±10)years old;there were 18 males and 12 females in the control group,with a mean age of(49±10) years.The ages and sex structure were matchable between the two groups(both P>0.05).②Serum visfatin levels was significantly higher in the MS patients than in the control subjects([97.57±40.69]μg/L vs [50.54±19.14]μg/L,P<0.05),but the adiponectin level was significantly lower([7.98±3.62] mg/L vs [13.55±5.72] mg/L,P<0.01).③In patients with MS,serum visfatin level was positively correlated with the waist circumference(Satandard partial regression cofficient=0.415,P=0.000),but not with other metabolic indices such as adiponectin,serum insulin,body mass index,HOMA-IR,or triglycerol;adiponectin level was positively correlated with high-density lipoprotein cholesterol(HDL-C)level(Satandard partial regression cofficient=0.312, P=0.004)but inversely with HOMA-IR(Satandard partial regression cofficient=-0.341,P=0.002)and the waist-hip ratio(Satandard partial regression cofficient=-0.211,P=0.048).Conclusions Significantly elevated visfatin and decreased adiponeetin levels occur in MS patients.Visfatin may play a role in the development of viscer al obesity,and adiponectin may inhibit insulin resistance and dyslipidiemia.No obvious correlation between visfatin and adiponectin is suggested.

Angiopoietin-like Protein 3 and Adiponectin Levels in Patients with Metabolic Syndrome.

Clinical Significance and Serum Concentration of Inflammatory Factor and Adiponectin in Children with Metabolism Syndrome

Elevated Plasma Angiopoietinlike Protein 5 (ANGPTL5) is More Positively Associated with Glucose Metabolism Disorders in Patients with Metabolic Syndrome

Clinical Significance of the Changes of Plasma Adiponectin Levels in Patients with Coronary Artery Disease

Correlation of serum visfatin and adiponectin levels with metabolic syndrome

[Correlation of Plasma Adiponectin and Components of Metabolic Syndrome].

Visfatin and Adiponectin Levels in Metabolic Syndrome Patients and Their Influencing Factors

Relationship between adipose cytokines and metabolic syndrome in newly diagnosed type 2 diabetes mellitus patients

Adipose Tissue Insulin Resistance is Closely Associated with Metabolic Syndrome in Northern Chinese Populations

Association of Triglyceride with Serum Polyunsaturated Fatty Acid in Patients with Metabolic Syndrome

Serum phospholipid fatty acid and insulin resistance in patients with metabolic syndrome

Urinary Mirna-29A-3p Levels Are Associated with Metabolic Parameters Via Regulation of IGF1 in Patients with Metabolic Syndrome.

Evaluation of angiopoietin-like protein 3 (ANGPTL3) levels in polycystic ovary syndrome

Serum CTRP1 level and its relationship with serum adiponectin level in elderly male metabolic syndrome patients

Serum betatrophin level increased in subjects with metabolic syndrome: a case-control study

The correlation study on angiopoietin-like protein 3 and diabetic angiopathies,dyslipidemia

Circulating zinc-α2-glycoprotein levels are low in newly diagnosed patients with metabolic syndrome and correlate with adiponectin

Association Between Serum Chemerin Concentrations and Clinical Indices in Obesity or Metabolic Syndrome: A Meta-Analysis

Gene Expressions of Adiponectin and Peroxisome Proliferators Activated Receptor Γ Correlate to Metabolic Syndrome

Meta-Analysis of Adiponectin As a Biomarker for the Detection of Metabolic Syndrome

Angiopoietin-like Protein 3 Markedly Enhanced in the Hyperlipidemia Related Proteinuria